HDAC9 and chronic obstructive pulmonary disease: HDAC activity in the PBMCs of COPD patients was significantly decreased by 40% as compared to that in healthy non-smokers (13.06 ± 5.95 vs. 21.39 ± 4.92 μM/μg, p < 0.001).